|
Current
Partnerships
Ribonomics
Inc. received its seed funding from a single corporate partner,
Medical & Biological Laboratory, Co. Ltd., a publicly traded
Japanese life science company that is the leading manufacturer
of autoimmune diagnostics in Japan. MBL has several subsidiaries,
in Japan and the United States, that extend across a wide
range of life science applications. To learn more about MBL,
please visit their website at www.mbl.co.jp.
In
addition to providing a seed investment in the company, MBL
and Ribonomics, Inc. began a collaboration in the summer of
2002 whereby the two companies will work to develop clinical
diagnostics and research products based on novel targets discovered
by Ribonomics, Inc.
|